Hematopoietic stem cells (HSCs) reside and selfrenew in the bone marrow (BM) niche. Overall, the signaling that regulates stem cell dormancy in the HSC niche remains controversial. Here, we demonstrate that TGF-b type II receptor-deficient HSCs show low-level Smad activation and impaired longterm repopulating activity, underlining the critical role of TGF-b/Smad signaling in HSC maintenance. TGF-b is produced as a latent form by a variety of cells, so we searched for those that express activator molecules for latent TGF-b. Nonmyelinating Schwann cells in BM proved responsible for activation. These glial cells ensheathed autonomic nerves, expressed HSC niche factor genes, and were in contact with a substantial proportion of HSCs. Autonomic nerve denervation reduced the number of these active TGF-b-producing cells and led to rapid loss of HSCs from BM. We propose that glial cells are components of a BM niche and maintain HSC hibernation by regulating activation of latent TGF-b.
INTRODUCTION
Self-renewal, differentiation, and the cell cycle of hematopoietic stem cells (HSCs) are thought to be regulated by the signals provided by specific niches in bone marrow (BM). Many different cell types have been characterized as contributors to the formation of HSC niches, such as osteoblasts (Zhang et al., 2003; Calvi et al., 2003; Arai et al., 2004) , endothelial cells (Kiel et al., 2005) , chemokine (C-X-C motif) ligand 12 (CXCL12)-abundant reticular (CAR) cells (Sugiyama et al., 2006) , and mesenchymal stem cells (MSCs) (Mé ndez-Ferrer et al., 2010). These cells are believed to provide microenvironments for HSC self-renewal, differentiation, mobilization, and hibernation by cell-to-cell contact and soluble factors, including angiopoietin-1 (Ang-1) (Arai et al., 2004) , Ca 2+ ions, CXCL12, sonic hedgehog, osteopontin, stem cell factor (SCF), and thrombopoietin (TPO). Contributions by as yet unidentified cells and factors have also been speculated (Kiel and Morrison, 2008) .
Most HSCs in the BM niche are in a hibernating state from which they are occasionally aroused to undergo cell division on average every 1-2 months (Sudo et al., 2000; Foudi et al., 2009; Bradford et al., 1997; Cheshier et al., 1999) . We recently demonstrated that lipid raft clustering is a key event in the regulation of HSC hibernation (Yamazaki et al., 2006) . Lipid raft clustering, as induced by cytokines, augmented signals that appeared essential for HSC entry into the cell cycle. Conversely ex vivo, inhibition of lipid raft clustering caused sustained nuclear accumulation of FoxO transcription factors and induced HSC hibernation. These findings established a critical role for lipid rafts in regulating the cell cycle, survival, and apoptosis of HSCs and uncovered a striking similarity between HSC hibernation and C. elegans dauer formation.
We hypothesized that a niche factor regulates the lipid raft clustering of HSCs in vivo. Screening of candidate niche signals revealed that transforming growth factor b (TGF-b) efficiently inhibited cytokine-mediated lipid raft clustering and induced HSC hibernation ex vivo, establishing TGF-b as a candidate niche signal in the control of HSC dormancy (Yamazaki et al., 2009) . TGF-b negatively regulates HSC and hematopoietic progenitor cell proliferation in vitro . TGF-bs are secreted as part of the large latent complex (LLC) consisting of TGF-b, latency-associated protein (LAP), and latent TGF-b binding protein-1 (LTBP-1) (Annes et al., 2003) . Because LTBP-1, a member of the LTBP/fibrillin family, covalently binds to extracellular matrix (ECM) proteins, the LLC accumulates in the ECM (Annes et al., 2003) . Under most conditions TGF-b in the LLC is inactive and is thus called latent TGF-b.
Therefore, TGF-b function is largely controlled by activation of latent TGF-b, a process that involves dissociation of bioactive TGF-b from LAP. As such, we further hypothesized that cells that activate latent TGF-b were a component of the BM HSC niche and sought them in BM. Glial fibrillary acidic protein (GFAP)-expressing cells (''glial cells'') were unexpectedly identified as the cells that principally process latent TGF-b into active TGF-b in BM. These GFAP-positive cells were nonmyelinating Schwann cells, which ensheath sympathetic nerves in BM. They produced niche factors and were in direct contact with a significant proportion of HSCs. Most strikingly, autonomic nerve denervation of BM reduced the number of these TGF-b secreting glial cells and led to the disappearance of CD34 À KSL HSCs.
RESULTS

TGF-b/Smad Signaling Is Active in HSCs in BM
To ascertain how TGF-b controls hibernation of HSCs, we first generated lymphocyte-deficient conditional TGF-b type II receptor (TbRII)-deficient mice. TGF-b binds to its receptor composed of TbRII and TGF-b type I receptor (TbRI) (Waite and Eng, 2003; Schmierer and Hill, 2007) . TGF-bs are multipotent cytokines that modulate cell growth, inflammation, matrix synthesis, and apoptosis (Waite and Eng, 2003; Schmierer and Hill, 2007) Figure 1B ). After binding to its ligand, the activated TGF-b receptor complex subsequently phosphorylates receptor-activated Smads (R-Smads) 2 and 3. R-Smads eventually heterodimerize with the common mediator Smad4. The resulting ternary complex translocates to the nucleus, where it recruits transcriptional cofactors to control expression of genes, including those involved in the cell cycle Waite and Eng, 2003; Schmierer and Hill, 2007) . Immunostaining in wild-type BM sections revealed that a high proportion of BM cells expressed phosphorylated Smad2/3 ( Figure 1C ). Smad2/3 have been shown to be activated broadly among different developmental stages of hematopoietic cells. Among members of the TGF-b family, Nodal and Activin are known to phosphorylate Smad2/3 . Although T cells can respond to both Activin and TGF-b (Rosendahl et al., 2003) , we have shown that HSCs do not respond to Activin or Nodal (Yamazaki et al., 2009) . To evaluate pSmad2/3 status within HSCs, BM sections were stained with anti-CD150, -CD48, -CD41, and -lineage marker antibodies (Kiel et al., 2005) and analyzed using ArrayScan technology (see Figure S1 available online). ArrayScan can quantitatively analyze BM histological sections containing large numbers of cells ( Figure S1A ) and can backtrack the location and phosphorylation status of individual very rare CD150
À Lin À HSCs ( Figure 1D ; Figure S1B ; scattergram gated in a red square, and Figures S1C and S1D). We confirmed that these HSCs were phosphorylated with Smad2/3 in a fashion similar to that in freshly isolated wild-type CD34 À KSL HSCs as previously observed ( Figure 1D ) (Yamazaki et al., 2009) .
We then examined the phosphorylation status of Smad2 and Smad3 in Tgfbr2
Rag2
À/À CD34 À KSL HSCs 2 weeks after pIpC injection. As expected, the levels of pSmad2/3 were significantly lower than those in Tgfbr2 Figure 1E ). In parallel with the reduction in p-Smad2/3 expression, a significantly higher proportion of Tgfbr2 del/À Rag2 À/À CD34 À KSL HSCs entered the cell cycle within 1 week compared with Tgfbr2
À/À HSCs, as determined by a bromodeoxyuridine (BrdU) incorporation assay ( Figure 1F ). Loss of Tgfbr2 was associated with reduced p-Smad2/3, increased cycling, and reduced long-term repopulating activity in HSCs. These results demonstrated for the first time that TGF-b/Smad signaling is active in BM HSCs and maintains their dormancy.
A Specialized Cell Type Produces Active TGF-b in BM TGF-b is produced by a variety of cells, including HSCs, in a latent form. However, HSCs cannot activate it by themselves (Yamazaki et al., 2009) . We thought that it may be critical to identify cell types that can activate latent TGF-b in order to understand the physiological role of TGF-b in BM. To address this issue, we used two antibodies: anti-LAP antibody and anti-TGF-b antibody. Both LAP and TGF-b exist as disulfide-linked homodimers, and these molecules are noncovalently associated, forming the latent TGF-b complex. Anti-LAP antibody was used to detect latent TGF-b. Anti-TGF-b antibody reacts with TGF-b only after TGF-b is released from the latent TGF-b complex. Anti-TGF-b antibody was used to detect active TGF-b. Citric acid treatment can release TGF-b from the latent TGF-b complex (Lyons et al., 1990) . The specificity of anti-TGF-b antibody was examined by ELISA. Anti-TGF-b antibody did not bind to TGF-b but bound to TGF-b after citric acid treatment ( Figure S2A ). As reported previously (Yamazaki et al., 2009) Figure S1 .
TGF-b in BM sections fixed with dry ice-cold ethanol. LAP was detected in various cells, including scattered megakaryocytes, well known to produce latent TGF-b abundantly (Figure 2A ), whereas distribution of active TGF-b was highly restricted to a minor population of LAP-positive cells that formed long, spindled structures distinct from VE-cadherin-positive blood vessels ( Figures 2B and 2C ). Of particular note, megakaryocytes became reactive to anti-TGFb antibody only after citric acid treatment ( Figure S2C ). These findings indicated that the fixation of BM sections with ethanol alone does not activate latent TGF-b and further supported the specificity of anti-TGFb antibody. Latent forms of TGF-b accumulate in the ECM through direct binding between the LTBP and ECM (Annes et al., 2003) . Although the precise mechanism of activation of latent TGF-b is not clear, the integrins avb6 and avb8 most likely facilitate proteolytic degradation of LAP by matrix metalloproteinases (Annes et al., 2003 (Annes et al., , 2004 Munger et al., 1999; Mu et al., 2002) . In this regard integrin function is tightly linked with proteolytic processes. LTBP was expressed in both long, spindled cells and megakaryocytes ( Figure S2D ), indicating that these cells produce abundant latent TGF-b. In contrast, integrin-b8 (Itgb8) was specifically expressed by the long, spindled-cell structure that marked abundantly for active TGF-b ( Figure 2D ), whereas integrin-b6 expression was not detected in any BM stromal or hematopoietic cells (data not shown).
BM Glial Cells Produce Active TGF-b
The aforementioned findings led us to identify BM cell types that express Itgb8. RT-PCR analysis revealed that hematopoietic cells and BM stromal cells did not express Itgb8 at all (Figure S3A) . We then focused on GFAP-positive glial cells because Schwann cells reportedly express Itgb8 ( Figure S3A ) (Cambier et al., 2005; Chernousov and Carey, 2003) . Schwann cells of neural crest origin in the peripheral nervous system are the counterparts of astrocytes in the central nervous system. There are two types of Schwann cells: myelinating and nonmyelinating. Myelinating Schwann cells, which provide the neural myelin sheath, express myelin basic protein (MBP), but not GFAP. In contrast, nonmyelinating Schwann cells, which ensheath several small axons, express GFAP, but not MBP. Myelination occurs for large axons 1-25 mm in diameter, whereas most postganglionic autonomic axons are less than 1 mm in diameter and are unmyelinated (Jessen and Mirsky, 2005) . To learn if the cells of interest were glial cells, we analyzed the expression in BM of GFAP, a glial cell-specific member of the intermediate filament family (Coulombe and Wong, 2004) . First, we characterized BM GFAP-positive cells in detail using GFAP promoter-driven GFP (GFAP-GFP) transgenic mice (Suzuki et al., 2003) . The vast majority of GFPpositive cells stained for active TGF-b ( Figure 3A ) and expressed Itgb8 and S100b, a marker antigen for glial cells (Figures S3B and S3C) . These cells were much smaller in diameter than other peripheral nerve cells, but the size and appearance of these GFAP-positive cells were very similar to those described for Schwann cells in the BM (Calvo and Forteza-Vila, 1970) . To confirm that these GFAP-positive cells were nonmyelinating Schwann cells, we examined them using a confocal laser microscope under high magnification. As shown in Figure lineage markers to identify HSCs as well as simultaneously staining BM sections with antibodies against GFAP, osteocalcin, and VE-cadherin. We then evaluated these sections quantitatively by ArrayScan to determine the positional relationships between HSCs and BM glial cells ( Figure 4A ). GFAP-expressing glial cells were in direct contact with 23.3% ± 5.4% of Figures 4B and 4C ), whereas 13.3% ± 4.2% and 30.7% ± 3.7% of HSCs were in contact, respectively, with osteocalcin-expressing osteoblastic cells and VE-cadherin expressing vascular cells ( Figures 4B, 4D , and 4E). Although 32.7% ± 5.7% of HSCs lay apart from these cells ( Figure 4B ), this may reflect our failure to detect HSC Glial cells have never been examined for a niche cell-like capacity to support HSCs. Although BM cells enriched in Schwann cells could not be prepared, Schwann cells prepared from sciatic nerves expressed Tgfb1, Tgfb2, and Tgfb3 as well as Itgb8. Surprisingly, they also expressed major HSC niche factor genes, including Cxcl12, c-kit ligand (kitl), anginpoitin-1 (Angpt1), and Tpo ( Figure S6 ). See also Figures S3, S4 , and S5, and Movie S1.
Denervation of Sympathetic Nerve Results in Loss of HSCs
To provide direct evidence that BM Schwann cells are a component of the BM niche and were responsible for the maintenance of HSCs' hibernation state, we attempted to delete ensheathing glial cells in BM via Wallerian degeneration by transecting postganglionic sympathetic nerves directly (Fernando et al., 2002) . Although denervation of sciatic myelinated motor axons was reported to induce proliferation of myelinating Schwann cells (Murinson and Griffin, 2004) , other studies indicated that Schwann cells undergo prompt apoptotic cell death in the nerve distal to axotomy both in neonates (Grinspan et al., 1996) and in adult rodents (Sulaiman et al., 2002) . lumbar sympathetic trunk was cut unilaterally at the level of L2, L3, and L4 to denervate sympathetic nerves to the biceps femoris muscle and the BM, with a sham operation performed contralaterally. This surgical procedure spared motor and sensory nerves, leaving the animal's motion intact (Noguchi et al., 1999) , and resulted in significant decreases in the number of GFAP-positive cells as well as of active TGF-b-positive cells ( Figure 5A ). Loss of GFAP-positive cells was also confirmed by S100b staining (data not shown). Although total BM cells did not differ significantly in number between left and right femora (data not shown), loss of HSCs on the denervated side was manifested as early as day 3 after surgery, and HSC numbers fell to one-fifth of those in contralateral BM by day 7 (Figures 5B and 5C ). Although we cannot exclude the possibility that sympathetic denervation induces secondary injury, we confirmed that the integrity of other BM niche components such as VE-cadherin-positive endothelial cells, PDGFRa-positive MSCs, and osteocalcin-positive osteoblasts remained intact at 1 week after denervation ( Figure 5D ).
To confirm the loss of HSCs after denervation, we performed competitive repopulation analyses using BM cells harvested 1 month after sympathetic nerve transfection. One million cells from denervated or contralateral BM were transplanted into lethally irradiated CD45-congenic mice together with 1 3 10 6 competitor BM cells (also from CD45 congenic mice). Three months later, donor chimerism in PB was analyzed. The results showed significantly lower chimerism achieved using BM cells derived from the denervated side than that derived from the sham-operated contralateral side (denervated BM cells, 12.4% ± 2.4%: control BM cells, 53.5% ± 6.2%) ( Figure 6A ), supporting our observation that the frequency of HSCs was reduced by the effects of denervation. We also performed competitive repopulation assays using CD34 À KSL cells purified from denervated BM in comparison with those from control BM and observed no significant difference between them ( Figure 6B ). These results support the interpretation that the quantity but not the quality of HSCs is responsible for decreased reconstitution activity in denervated BM. To examine the possibility that HSC numbers were reduced in BM because of their mobilization, we examined PB and spleen for the presence of CD34 À KSL HSCs before and after denervation but did not observe any increase of HSCs either in PB or in spleen ( Figure 6C ; data not shown).
Notably, as was the case with Tgfbr2 del/À Rag2 À/À HSCs in Fig- ure 1E, the levels of pSmad2/3 were significantly downregulated in HSCs after selective denervation ( Figure 6D ). To examine cell cycle status, we then isolated HSCs from denervated femora of mice that had been given BrdU for 7 days. The HSCs were stained with FITC-conjugated anti-BrdU antibody and analyzed by ArrayScan. Significantly higher proportions of HSCs isolated from denervated BM were positive for BrdU than of those from control BM ( Figure 6E ). These data strongly indicate that the glial cell component of the niche is responsible for the maintenance of HSC hibernation in BM by regulating the process by which latent TGF-b is activated. This concept was supported by the effects of exogenous latent and active TGF-b on HSCs in denervated mice. Beginning 1 week after denervation, either latent or active TGF-b was infused into mice every other day for 1 week, and BrdU-containing water was given throughout the same week. Cell cycle analysis at day 14 after denervation revealed that active TGF-b significantly suppressed active cycling of HSCs in denervated mice, whereas latent TGF-b did not ( Figure 6F ). These results confirm the cytostatic effect of active TGF-b on HSCs and underline the role of the glial cell component of the niche in converting latent TGF-b into active TGF-b.
DISCUSSION
We have shown in this study that Smad2 and Smad3 are activated in HSCs in BM. Tgfbr2 del/À HSCs showed profoundly low levels of Smad2 and Smad3 phosphorylation and were defective À KSL HSCs were purified from control and denervated BM at day 7 after denervation, stained with anti-p-Smad2/3 antibody, and assayed by ArrayScan. **p < 0. 001. (E) Cell cycle status of HSCs in denervated BM. One week after denervation, mice were fed with BrdU-containing water for 7 days, then CD34 À KSL HSCs were isolated from control or denervated BM, stained with anti-BrdU antibody, and analyzed by ArrayScan. Data are presented as mean ± SD (n = 3). **p < 0. 001. (F) Restoration of HSC dormancy by infusion of active TGF-b. One week after denervation, administration of either latent or active TGF-b (lTGF and aTGF, respectively) began, infused intraperitoneally into mice every other day at a dose of 40 mg/kg. BrdU in drinking water also was begun. Intraperitoneal infusions and BrdU administration both were given for 1 week. At day 14 after denervation, CD34 À KSL HSCs were isolated, stained with anti-BrdU antibody, and analyzed by ArrayScan. Data are presented as mean ± SD (n = 3). **p < 0. 001. with respect to the long-term repopulating capacity of hematopoiesis. As previously reported (Yamazaki et al., 2006 (Yamazaki et al., , 2009 , TGF-b may tune down cytokine signals by inhibiting cytokineinduced lipid raft clustering. By doing so, TGF-b keeps the PI3K-Akt pathway suppressed and induces cyclins D1, D2, and D3 distancing from the nucleus, whereas it stabilizes FoxO1, 3a, and 4, permitting them to function in the nucleus. TGF-b also activates Smad2 and Smad3 and supposedly regulates transcription of p57 Kip2 for example, the cyclin-dependent kinase inhibitor gene highly expressed in dormant HSCs (Yamazaki et al., 2006) . Regulation of these machineries is reportedly critical to maintenance of the dormant state in HSCs (Oguro and Iwama, 2007; Yilmaz et al., 2006; Zhang et al., 2006; Kozar et al., 2004; Tothova et al., 2007; Miyamoto et al., 2007; Yoshihara et al., 2007) . Although the defects in Tgfbr2 del/À HSCs were relatively mild compared with those in mice deficient in Smad4 (Karlsson et al., 2007) , which acts at a common level of convergence for all TGF-b superfamily signals, all these in vivo findings define the TGF-b/Smad signal as one of the critical niche signals in the maintenance of HSCs. Correspondingly, a critical role of TGF-b has recently been reported in the maintenance of quiescence and immaturity of melanocyte stem cells (Nishimura et al., 2010) . Therefore, the TGF-b signal could have a general impact on the maintenance of stem cell dormancy. Latent TGF-b, produced by a variety of BM cells, is broadly distributed within BM. However, active TGF-b is exclusively detectable in nonmyelinating Schwann cells that lay in parallel with blood vessels. These glial cells in BM express not only stem cell niche genes, but also Itgb8. Upon cell-to-cell contact, integrin-avb8 of Schwann cells supposedly binds to LAP and changes the conformation of the latent TGF-b complex. The consequent exposure of the cleavage site for proteolytic degradation by plasmin and metalloproteinases results in production of active TGF-b. Thus, in BM, function of TGF-b appears tightly regulated by an activation process. Active TGF-b triggers the Smad signaling pathway, causing hibernation in HSCs. Given that TGF-bs are prone to degradation, they may act locally at the glial niche without diffusing to distant progenitor cells. That TGF-b should regulate HSCs locally is reasonable if the highly cytostatic activity of TGF-b is to be restricted to dormant HSCs.
Smad2 and Smad3 were activated in most HSCs, whereas only 25% of HSCs were in contact with the glial component of the niche. This finding raises the possibility that HSCs, depending on their activation status, shift among various compartments of the niche. Once Smad2 and Smad3 are activated via the glial component of the niche, HSCs may retain Smads in active form, even after relocation into another compartment, until the HSCs receive cues for cell division. Alternatively, by shifting away from glial cells, Smad signaling is downregulated, and therefore, HSCs may regain the ability to form lipid raft clusters and to be aroused from hibernation to enter the cell cycle. Another possibility is that usage of signaling molecules by different TGF-b superfamily ligands overlaps. Absence of TbRI reportedly does not affect the hematopoietic system . Here, we demonstrated HSC abnormalities in Tgfbr2-deficient mice. These observations are in accordance with the fact that Tgfbr2 is expressed in HSCs, but Tgfbr1 is not (Utsugisawa et al., 2006; Yamazaki et al., 2009 ). This adds to the complex roles of ligands, receptors, and Smads in TGF-b signaling in HSCs (Karlsson et al., 2007) . A recent study has demonstrated that mice deficient in both Smad1 and Smad5 have no hematopoietic abnormalities (Singbrant et al., 2010) . On the other hand, mice deficient in Smad4 show HSC abnormalities similar to those in Tgfbr2-deficient mice (Karlsson et al., 2007) . These data suggest that signaling downstream from TbRII but not from bone morphogenetic protein receptors plays a role in the maintenance of HSCs in BM. However, how TGF-b conveys signals into the cell without TbRI remains to be elucidated. TbRI is a member of the ALK family. As far as we and others have been able to determine (Utsugisawa et al., 2006) , expression of other members of the ALK family in HSCs is barely detectable. To understand the whole picture of regulation of HSC dormancy by TGF-b superfamily, further characterization is required.
To observe the contribution of the nervous system to hematopoiesis, we performed ischiac nerve denervation (data not shown) as well as selective sympathetic denervation. Surprisingly, in both cases, denervation resulted in significant decreases in the number of BM glial cells and of cells expressing active TGF-b. In parallel we observed a drastic reduction in HSC numbers, with the HSCs present found to be actively cycling. This finding supports the idea that neural regulation plays a role in homeostasis of hematopoiesis. Other studies have also shown that signals from the sympathetic nervous system enhance HSC egression from the BM osteoblastic niche through suppression of Cxcl12 production (Katayama et al., 2006) . Circadian noradrenalin secretion by the sympathetic nervous system also regulates Cxcl12 expression in the BM microenvironment, thereby regulating release of HSCs from their niche (Mé ndezFerrer et al., 2008) . Moreover, catecholaminergic pathways can promote human CD34 + cell migration and engraftment by acting directly on HSC/progenitor cells (Spiegel et al., 2007) . This sympathetic nerve regulation of HSC maintenance reportedly is mediated indirectly by Nestin + MSCs expressing b3-adrenergic receptor (Mé ndez-Ferrer et al., 2010) . However, the present work implicates BM glial cells of the autonomic nervous system in direct regulation of HSCs. By regulating the activation process of TGF-b, these glial cells appear to control hibernation of HSCs in BM. How these two components of the BM niche are related in the maintenance of homeostasis of HSCs under the influence of the autonomic nervous system remains an intriguing issue. Identification of glial cells as BM HSC niche components opens up a new area of research that links the neural and hematopoietic systems.
EXPERIMENTAL PROCEDURES
Mice C57BL/6 (B6-Ly5.2) mice were purchased from SLC (Shizuoka, Japan). C57BL/6 mice congenic for the Ly5 locus (B6-Ly5.1) were bred and maintained at Sankyo Lab Service (Tsukuba, Japan). C57BL/6-Ly5.1/Ly5.2 F 1 mice were used for competitive reconstitution assays. Tgfbr2
Rag2
À/À mice were obtained by mating Tgfbr2 +/À mice (Oshima et al., 1996) + KSL MPPs were purified from BM of 2-month-old mice. The cells were stained with an antibody cocktail consisting of biotinylated anti-Gr-1, -Mac-1, -B220, -CD4, -CD8, and -Ter-119 monoclonal antibodies (lineage-marker cocktail) (PharMingen, San Diego, CA, USA). Lineage-positive cells were depleted with anti-rat MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany). The remaining cells were further stained with fluorescein isothiocyanate (FITC)-conjugated anti-CD34, phycoerythrin (PE)-conjugated anti-Sca-1, and allophycocyanin (APC)-conjugated antic-Kit antibodies (PharMingen). Biotinylated antibodies were detected with streptavidin-APC-Cy7 (PharMingen). Analysis and cell sorting were performed on a MoFlo using Summit software (Beckman Coulter, Fullerton, CA, USA), and results were analyzed with FlowJo software (Tree Star, Ashland, OR, USA).
Immunofluorescence Staining of BM Sections
Frozen BM sections were prepared and immunostained according to the Kawamoto method (Kawamoto, 2003) . BM sections were fixed using dry ice/ ethanol or 4% paraformaldehyde (PFA). Immunofluorescence data were obtained and analyzed with a TCS SP2 AOBS confocal microscope (Leica, Microsystems, Tokyo) or a Cellomics ArrayScan VTI HCS Reader (Thermo Scientific, Pittsburgh), a modular high-content screening instrument designed for high-capacity automated fluorescence cell imaging with quantitative analysis. The immunofluorescence-microscopy images of BM sections were automatically obtained, using integrated reader software, from multiple replicates. Markers and antibodies used were: 4,6-diamidino-2-phenylindole (DAPI), a DNA marker; Alexa 405-conjugated goat anti-rabbit IgG, Alexa 488-conjugated goat anti-chicken IgG, and Alexa 647-conjugated goat anti-rabbit IgG (Molecular Probes, Carlsbad, CA, USA); rabbit anti-GFAP (Dako, Glostrup, Denmark); goat anti-LAP (latent TGF-b) and rabbit anti-TGF-b (R&D systems, Minneapolis); rabbit anti-osteocalcin (Lifespan, Seattle); rabbit anti-Itgb8 and anti-LTPB1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA); rabbit antiphospho-Smad2/3 (Chemicon, Temecula, CA, USA); chicken anti-neurofilament (Millipore, Billerica, MA, USA); chicken anti-nestin and rabbit antiS100b (Abcam, Cambridge); rabbit anti-tyrosine hydroxylase (Cell signaling, Charlottesville, VA, USA); and Alexa 488-conjugated rat anti-VE-cadherin, FITC-conjugated rat anti-CD41, FITC-conjugated anti-CD48, FITC-conjugated lineage-marker cocktail, PE-conjugated rat anti-CD150, APC-conjugated rat anti-CD150, and APC-conjugated rat anti-PDGFRa (BioLegend, San Diego, CA, USA).
Immunofluorescence Staining of HSCs CD34
À KSL cells were sorted into a droplet of serum-free culture medium made on glass slides. The sorted cells were incubated at 37 C for the indicated time periods. After fixation with 2% PFA and blocking in 10% goat serum for 1 hr at room temperature, cells were incubated with a primary antibody for 12 hr at 4 C. The cells were then washed and were incubated with a secondary antibody for 30 min at room temperature. Immunofluorescence data were obtained and analyzed with a Cellomics ArrayScan VTI HCS Reader (Thermo Scientific).
Preparation of Primary Schwann Cells GFAP-positive primary glial cells were prepared from the sciatic nerve of adult C57BL/6 GFAP-GFP mice using forceps under the stereoscopic microscope (Leica, Microsystems, Tokyo).
Competitive Repopulation Assays
Competitive repopulation assays were performed using the Ly5 congenic mouse system. A total of 1 3 10 6 BM cells from Tgfbr2 
Denervation of BM
The lumbar sympathetic trunk was cut unilaterally at the level of L2, L3, and L4 to denervate sympathetic nerves to the biceps femoris muscle and the BM. After the wounds were sutured, the animals were returned to their cages for 3-30 days before sacrifice and study. This surgical procedure spares motor and sensory nerves, leaving the animal's motion intact (Noguchi et al., 1999) .
Cell Cycle Analysis
To investigate the turnover rate of CD34 À KSL cells, BrdU (Sigma-Aldrich) was administered continuously to mice via drinking water (0.5 mg/ml). After 1 week, CD34 À KSL cells were isolated and stained with FITC-conjugated anti-BrdU antibody (Molecular Probes). The cells then were analyzed by ArrayScan.
Administration of TGF-b to Denervated Mice
Beginning on the seventh day after denervation, either latent TGF-b (recombinant human LAP [TGF-b1]; R&D Systems) or active TGF-b (recombinant human TGF-b1; R&D Systems) was infused intraperitoneally into mice every other day at a dose of 40 mg/kg.
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